MIAMI--(BUSINESS WIRE)--After 8 years of successive growth, Lifeline Pharmaceuticals, a Florida-based pharmaceuticals wholesale distribution company, has invested in additional distribution capacity in the state of Mississippi.
The new distribution center, scheduled to open during the first quarter of 2015, satisfies all state and federal requirements, employs cutting-edge technology and will assist in meeting the growing demand of Lifeline’s national customer base while significantly improving its logistics capabilities.
Rick Nielsen, President & CEO, commented on the expansion: "We are very pleased to announce the opening of our new distribution center in Mississippi. This new facility will enhance our overall presence and will enable us to bring greater efficiencies and added value to our customers while increasing our market share. The business environment in Mississippi is excellent and we look forward to our expansion into the Magnolia State.”
About Lifeline Pharmaceuticals:
Lifeline Pharmaceuticals is a nationwide pharmaceuticals distributor and the largest independent pharmaceutical wholesaler of brand and generic injectables in the Southeastern United States. Lifeline is an Authorized Distributor of Record (ADR) for many major pharmaceutical brands, and is committed to the safe and ethical distribution of pharmaceutical products.
Lifeline Pharmaceuticals’ product line includes medical-surgical products, surgical-related injectables, specialty pharmaceuticals, generic and branded chemotherapy products, vaccines, albumin, IVIG, coagulation factors, immune globulins, and other specialty injectables.
Lifeline Pharmaceuticals is headquartered in Florida, with locations in the U.S. Virgin Islands and Mississippi.
For more information visit www.lifelinepharm.com.